Bénédicte Menn

Private Equity Investor bei

Oxford University Innovation Ltd.

Consumer Services

Finance

Health Technology

Profil

Bénédicte Menn founded Neurokin SA in 2003, where she worked as Project Leader from 2009 to 2014.
Dr. Menn also currently works at Oxford University Innovation Ltd., as Senior Investment Manager.
Dr. Menn received her undergraduate degree in 1990 from Ecole Nationale d'Administration.

Aktive Positionen von Bénédicte Menn

Unternehmen	Position	Beginn
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Private Equity Investor	01.01.2017

Alle aktiven Positionen von Bénédicte Menn

Ehemalige bekannte Positionen von Bénédicte Menn

Unternehmen	Position	Ende
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Gründer	11.03.2014

Sehen Sie sich die Erfahrung von Bénédicte Menn im Detail an

Ausbildung von Bénédicte Menn

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Bénédicte Menn im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Ecole Nationale d'Administration Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Finance
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Health Technology